Nutrition 21 Revives Under Leadership Of Former Pharma Exec Satow
This article was originally published in The Tan Sheet
Executive Summary
Michael Satow, formerly of JDS Pharmaceuticals, tries his hand in the nutritional ingredients space as CEO of Nutrition 21. In a recent interview, Satow discussed his initial impressions of the industry and what potential he sees in a portfolio that includes Chromax chromium picolinate.
You may also be interested in...
Pharmavite Sitting Out Trendy Spin-Off Dance
"Otsuka is very, very committed to nutraceuticals generally, and supplements specifically,” says Pharmavite CEO Jeff Boutelle.
New Chapter For Nutrition21: Private Equity Owner
RoundTable Healthcare Partners establishes Everwell Health Holdings for investing in consumer health and wellness functional ingredient businesses; Nutrition21 is Everwell’s first investment.
FDA Revision Of NDI Draft Guidance Starts With Grandfathered List
Trade groups say FDA committed to revisiting issues in the NDI draft guidance including how firms prove ingredients’ grandfathered status, notifications required for ingredients or finished products and data necessary to demonstrate NDI safety. The agency’s decision followed a meeting between industry allies Sens. Hatch and Harkin and FDA Commissioner Hamburg.